ALTR Announces Promotion of James Beecham to Chief Executive Officer
Company Co-founder to lead next phase of expansion and growth Austin, Texas (October 10, 2022)—…
Company Co-founder to lead next phase of expansion and growth Austin, Texas (October 10, 2022)—…
The first episode, “Psychedelic Novelty – Before it was Cool,” introduces the company’s proprietary molecule…
FlareHawk Expandable Lumbar Interbody Fusion System Accelus Announces New Milestone with Its FlareHawk® Interbody Fusion…
JERSEY CITY, N.J., Oct. 11, 2022 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology…
Co-founder and Chairman Michael Ackermann plans to transition off Board of Directors Wendy Yarno will…
NEW YORK, Oct. 11, 2022 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS)…
New Survey Focused on Access Limitations of Approved Autologous CAR T Therapies Reveals Only 50%…
MARLBOROUGH, Mass., Oct. 11, 2022 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The…
Integration with the most widely used comprehensive electronic health record will expand clinician and patient…
Data to be featured in one poster and two oral presentations WATERTOWN, Mass., Oct. 11,…
GERMANTOWN, Md., Oct. 11, 2022 (GLOBE NEWSWIRE) — TeraImmune, Inc., a biotechnology company focused on…
– Clinical development operations focused on ongoing Phase 2b clinical trial of AB-2004 in autism;…
Two Presentations Featuring Thin Film Freezing Technology Selected for the Meeting’s Special Poster Collections Demonstrates…
66% of HPV 16-positive checkpoint inhibitor refractory patients are alive at median follow up of…
-Multiplex deletion of myeloid antigens CD33 and CLL-1 or CD33 and CD123 in human hematopoietic…
PURCHASE, N.Y., Oct. 11, 2022 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (Nasdaq: CGTX), announced the…
FDA’s End-of-Phase 2 written response provides positive feedback related to Chemistry, Manufacturing, and Controls (CMC)…
MIAMI and BARRANQUILLA, Colombia, Oct. 11, 2022 (GLOBE NEWSWIRE) — Procaps Group (NASDAQ: PROC) (“Procaps”),…
Collaboration aims to accelerate drug discovery and advance company’s tRNA synthetase platform SAN DIEGO, Oct….
BOTHELL, Wash., Oct. 11, 2022 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) announces the…